HWHG(SH:600079)2017-04-14 16:00Financial Performance - Net profit attributable to shareholders rose by 32.64% to CNY 197.65 million year-on-year[8] - Operating revenue grew by 24.16% to CNY 3.33 billion compared to the same period last year[8] - Basic earnings per share increased by 16.67% to CNY 0.14 per share[8] - Total operating revenue for the current period reached ¥3,329,530,640.35, an increase of 24.3% compared to ¥2,681,679,991.45 in the previous period[30] - Operating profit for the current period was ¥336,862,667.34, representing a 33.1% increase from ¥253,080,013.90 in the previous period[30] - Net profit attributable to shareholders of the parent company was ¥197,647,556.12, a rise of 32.6% compared to ¥149,007,049.85 in the prior period[30] - The company reported a total comprehensive income of ¥275,335,031.35, up from ¥193,017,421.09 in the prior period, indicating a growth of 42.7%[31] - Basic and diluted earnings per share increased to ¥0.14 from ¥0.12, reflecting a growth of 16.7%[31] Assets and Liabilities - Total assets increased by 4.76% to CNY 27.69 billion compared to the end of the previous year[8] - Non-current assets totaled ¥15.80 billion, an increase of 6.56% from ¥14.82 billion[24] - Current liabilities rose to ¥10.92 billion, compared to ¥10.06 billion, marking an increase of 8.58%[24] - Total liabilities reached ¥15.37 billion, up from ¥14.45 billion, reflecting a growth of 6.38%[24] - Owner's equity totaled ¥12.31 billion, an increase from ¥11.98 billion, representing a growth of 2.76%[24] - Total cash inflow from financing activities was 1,852,218,360.00 RMB, up from 865,000,000.00 RMB in the previous period, reflecting increased borrowing and investment[41] Cash Flow - Cash flow from operating activities showed a significant decline of 913.14%, resulting in a net outflow of CNY 327.59 million[8] - Operating cash flow net amount decreased by 913.14% to CNY -327,588,355.35, due to increased tax payments and cash paid to employees[16] - The net cash flow from operating activities was -153,609,646.28 RMB, compared to -50,556,475.75 RMB in the previous period, indicating a decline in operational performance[40] - The net cash flow from investing activities was -573,867,203.79 RMB, compared to -1,109,762,367.48 RMB in the previous period, showing a reduction in cash outflow for investments[40] - The ending cash and cash equivalents balance was 632,294,042.73 RMB, slightly down from 639,229,288.11 RMB in the previous period[41] Shareholder Information - The total number of shareholders reached 36,585 by the end of the reporting period[11] - The largest shareholder, Wuhan Contemporary Science and Technology Industry Group, holds 24.49% of the shares[11] - The first employee stock ownership plan involved 880 participants, raising a total of CNY 238.63 million[17] Expenses and Investments - Management expenses increased by 36.36% to CNY 326,572,079.95, mainly due to the acquisition of Epic Pharma, LLC[16] - Financial expenses rose by 41.51% to CNY 94,852,789.33, primarily from interest on acquisition loans for Epic Pharma, LLC[16] - Investment income decreased by 79.74% to CNY 7,320,243.49, mainly due to a decline in profits from Tianfeng Securities Co., Ltd.[16] - Cash outflow for purchasing fixed assets and other long-term assets was 162,854,203.79 RMB, significantly higher than 875,919.76 RMB in the previous period[40] Government and Other Income - The company reported non-operating income of CNY 12.14 million from government subsidies related to normal business operations[8] - Other income increased by 42.40% to CNY 15,800,912.28, driven by government subsidies related to assets[16]